Serial changes in serum procalcitonin, interleukin 6, and C-reactive protein levels according to non-specific surgical stimulation

Clinical Chemistry and Laboratory Medicine

Volumn 53, Issue 4, 2015, Pages 549-558

  Jun, Kyung Ran ^a   Lee, Jeong Neo ^a   Song, Sae Am ^a   Oh, Seung Hwan ^a   Lee, Ja Young ^a   Shin, Jeong Hwan ^a   Kim, Hye Ran ^a  

^a Inje University College of Medicine   (South Korea)

Author keywords

C reactive protein; interleukin 6; procalcitonin; prognosis; serial; surgery

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; PROCALCITONIN; BIOLOGICAL MARKER; CALCITONIN; PROTEIN PRECURSOR;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD LEVEL; DEMOGRAPHY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEPSIS; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; BLOOD; METABOLISM; MIDDLE AGED; PATIENT MONITORING; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOMARKERS; C-REACTIVE PROTEIN; CALCITONIN; FEMALE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; MONITORING, INTRAOPERATIVE; PERIOPERATIVE PERIOD; PROTEIN PRECURSORS; YOUNG ADULT;

EID: 84925717554     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2014-0090     Document Type: Article

References (31)

1. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, et al. SCCM/ESICM/ACCP/ATS/SIS. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 2003;31:1250-6.
2. Di Somma S, Magrini L, Travaglino F, Lalle I, Fiotti N, Cervellin G, et al. Opinion paper on innovative approach of biomarkers for infectious diseases and sepsis management in the emergency department. Clin Chem Lab Med 2013;51:1167-75.
3. Bloos F, Reinhart K. Rapid diagnosis of sepsis. Virulence 2014;5:1-7.
4. Endo S, Aikawa N, Fujishima S, Sekine I, Kogawa K, Yamamoto Y, et al. Usefulness of procalcitonin serum level for the discrimination of severe sepsis from sepsis: a multicenter prospective study. J Infect Chemother 2008;14:244-9.
5. Mokart D, Merlin M, Sannini A, Brun JP, Delpero JR, Houvenaeghel G, et al. Procalcitonin, interleukin 6 and systemic inflammatory response syndrome (SIRS): early markers of postoperative sepsis after major surgery. Br J Anaesth 2005;94:767-73.
6. Harbarth S, Holeckova K, Froidevaux C, Pittet D, Ricou B, Grau GE, et al. Diagnostic value of procalcitonin, interleukin-6, and inter-leukin-8 in critically ill patients admitted with suspected sepsis. Am J Respir Crit Care Med 2001;164:396-402.
7. Nie X, Wu B, He Y, Huang X, Dai Z, Miao Q, et al. Serum procal-citonin predicts development of acute kidney injury in patients with suspected infection. Clin Chem Lab Med 2013;51:1655-61.
8. Billeter A, Turina M, Seifert B, Mica L, Stocker R, Keel M. Early serum procalcitonin, interleukin-6, and 24-hour lactate clearance: useful indicators of septic infections in severely traumatized patients. World J Surg 2009;33:558-66.
9. Uusitalo-Seppälä R, Koskinen P, Leino A, Peuravuori H, Vahlberg T, Rintala EM. Early detection of severe sepsis in the emergency room: diagnostic value of plasma C-reactive protein, procalci-tonin, and interleukin-6. Scand J Infect Dis 2011;43:883-90.
10. Wiedermann FJ, Kaneider N, Egger P, Tiefenthaler W, Wieder-mann CJ, Lindner KH, et al. Migration of human monocytes in response to procalcitonin. Crit Care Med 2002;30:1112-7.
11. Meisner M, Schmidt J, Hüttner H, Tschaikowsky K. The natural elimination rate of procalcitonin in patients with normal and impaired renal function. Intensive Care Med 2000;26:S212-6.
12. Barbic J, Ivic D, Alkhamis T, Drenjancevic D, Ivic J, Harsanji-Drenjancevic I, et al. Kinetics of changes in serum concentrations of procalcitonin, interleukin-6, and C-reactive protein after elective abdominal surgery. Can it be used to detect postoperative complications? Coll Antropol 2013;37:195-201.
13. Song M, Kellum JA. Interleukin-6. Crit Care Med 2005;33: S463-5.
14. Tsalik EL, Jaggers LB, Glickman SW, Langley RJ, van Velkinburgh JC, Park LP, et al. Discriminative value of inflammatory biomarkers for suspected sepsis. J Emerg Med 2012;43:97-106.
15. Gabay C, Kushner I. Acute-phase proteins and other systemic responses to inflammation. N Engl J Med 1999;340:448-54.
16. Hoeboer SH, Groeneveld AB. Changes in circulating procal-citonin versus C-reactive protein in predicting evolution of infectious disease in febrile, critically ill patients. PLoS One 2013;8:e65564.
17. Tschaikowsky K, Hedwig-Geissing M, Braun GG, Radespiel-Troeger M. Predictive value of procalcitonin, interleukin-6, and C-reactive protein for survival in postoperative patients with severe sepsis. J Crit Care 2011;26:54-64.
18. Dörge H, Schöndube FA, Dörge P, Seipelt R, Voss M, Messmer BJ. Procalcitonin is a valuable prognostic marker in cardiac surgery but not specific for infection. Thorac Cardiovasc Surg 2003;51:322-6.
19. Sarbinowski R, Arvidsson S, Tylman M, Oresland T, Bengtsson A. Plasma concentration of procalcitonin and systemic inflammatory response syndrome after colorectal surgery. Acta Anaesthe-siol Scand 2005;49:191-6.
20. Molter GP, Soltész S, Kottke R, Wilhelm W, Biedler A, Silomon M. Procalcitonin plasma concentrations and systemic inflammatory response following different types of surgery. Anaesthesist 2003;52:210-7.
21. Lindberg M, Hole A, Johnsen H, Asberg A, Rydning A, Myrvold HE, et al. Reference intervals for procalcitonin and C-reactive protein after major abdominal surgery. Scand J Clin Lab Invest 2002;62:189-94.
22. Bone RC, Balk RA, Cerra FB, Dellinger RP, Fein AM, Knaus WA, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992;101:1644-55.
23. Riché FC, Cholley BP, Laisné MJ, Vicaut E, Panis YH, Lajeunie EJ, et al. Inflammatory cytokines, C reactive protein, and procalci-tonin as early predictors of necrosis infection in acute necrotiz-ing pancreatitis. Surgery 2003;133:257-62.
24. Giamarellos-Bourboulis EJ, Giannopoulou P, Grecka P, Voros D, Mandragos K, Giamarellou H. Should procalcitonin be introduced in the diagnostic criteria for the systemic inflammatory response syndrome and sepsis? J Crit Care 2004;19:152-7.
25. Tang BM, Eslick GD, Craig JC, McLean AS. Accuracy of procalci-tonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis. Lancet Infect Dis 2007;7:210-7.
26. Sablotzki A, Friedrich I, Mühling J, Dehne MG, Spillner J, Silber RE, et al. The systemic inflammatory response syndrome following cardiac surgery: different expression of proinflamma-tory cytokines and procalcitonin in patients with and without multiorgan dysfunctions. Perfusion 2002;17:103-9.
27. Miguel D, Prieto B, Álvarez FV. Biological variation and prognosis usefulness of new biomarkers in liver transplantation. Clin Chem Lab Med 2013;51:1241-9.
28. Meisner M, Adina H, Schmidt J. Correlation of procalcitonin and C-reactive protein to inflammation, complications, and outcome during the intensive care unit course of multiple-trauma patients. Crit Care 2006;10:R1.
29. Bihan H, Becker KL, Snider RH, Nylen E, Vittaz L, Lauret C, et al. Calcitonin precursor levels in human medullary thyroid carcinoma. Thyroid 2003;13:819-22.
30. Giovanella L, Suriano S, Ricci R, Ravani P, Ceriani L. Circulating procalcitonin in aseptic carcinoma patients: a specificity study with (18)F-fluorodeoxyglucose positron-emission tomography/computed tomography as benchmark. Clin Chem Lab Med 2010;48:1163-5.
31. Vodnik T, Kaljevic G, Tadic T, Majkic-Singh N. Presepsin (sCD14-ST) in preoperative diagnosis of abdominal sepsis. Clin Chem Lab Med 2013;51:2053-62.